Esperion Therapeutics
ESPR
ESPR
152 hedge funds and large institutions have $336M invested in Esperion Therapeutics in 2024 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 131 → 152 (+21)
3.61% more ownership
Funds ownership: 64.1% → 67.71% (+3.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
152
Holding in Top 10
2
Calls
$8.22M
Puts
$3.49M
Top Buyers
| 1 | +$36.7M | |
| 2 | +$21.4M | |
| 3 | +$20.5M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$15.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$11.7M |
Top Sellers
| 1 | -$9.57M | |
| 2 | -$9.43M | |
| 3 | -$5.53M | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$3.25M |
| 5 |
WCM
Whitefort Capital Management
New York
|
-$2.65M |